Bioprocessing Facilities and FDA Inspection Problems

被引：0

|

作者：

Rader, Ronald A. ^{[1
]}

机构：

[1] BioPlan Associates, Tech Res, Rockville, MD 20850 USA

来源：

BIOPHARM INTERNATIONAL | 2019年 / 32卷 / 05期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

收藏

页码：12 / 15

页数：4

相关论文

共 50 条

[21] FDA clarifies worldwide inspection policies
Wechsler, Jill
Pharmaceutical Technology, 2018, 42 (10) : 14 - 15
[22] How to Prepare for an FDA GxP Inspection
Demby, Glenn
Lab Manager, 2023, 18 (04): : 38 - 40
[23] FDA Inspection of Investigator Sites in Italy
N. Brunetti
M. Roncolato
S. Zancan
Drug information journal : DIJ / Drug Information Association, 1997, 31 (1): : 187 - 191
[24] LAW GOVERNING FDA FACTORY INSPECTION
GRAHAM, AJ
FOOD DRUG COSMETIC LAW JOURNAL, 1966, 21 (05): : 275 - 282
[25] IMPROVING THE EFFECTIVENESS OF FDA DRUG INSPECTION
KLIMBERG, R
REVELLE, C
COHON, J
OPERATIONS RESEARCH, 1992, 40 (05) : 845 - 855
[26] Chinese firm hampers FDA inspection
Tremblay, Jean-Francois
CHEMICAL & ENGINEERING NEWS, 2017, 95 (02) : 13 - 13
[27] FDA Clarifies Worldwide Inspection Policies
Wechsler, Jill
BIOPHARM INTERNATIONAL, 2018, 31 (10) : 8 - 9
[28] FDA Electronic Inspection System updated
不详
JOURNAL OF ENVIRONMENTAL HEALTH, 2000, 62 (07) : 65 - 65
[29] TREATMENT ALTERNATIVES TO MINIMIZE RISK ASSOCIATED WITH RELEASES FROM BIOPROCESSING FACILITIES
WICKRAMANAYAKE, GB
EVERS, DP
VIGON, BW
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1990, 199 : 174 - AGRO
[30] AN INSPECTION POLICY MODEL FOR PRODUCTION FACILITIES
LUSS, H
MANAGEMENT SCIENCE, 1983, 29 (09) : 1102 - 1109

← 1 2 3 4 5 →